For the Inventor, By the Inventor

Enter assignee name

Maple Grove, MN, United States of America

Coaxia, Inc.

USPTO Granted Patents = 49

% Expired Patents = 42.9

Forward Citations = 4,946

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Denise R Barbut (49 out of 94 patents)

Jon St Germain (9 out of 42 patents)

Peter Trexler Keith (6 out of 165 patents)

4. Steven Wayne Berhow (5 out of 13 patents)

5. Russel H Patterson (4 out of 5 patents)

6. Mark-Hein Heinemann (3 out of 4 patents)

7. Joel R Munsinger (2 out of 22 patents)

Core Competencies:

Cerebral Perfusion Augmentation

Flow Reversal

Distal Embolization Prevention

Partial Aortic Occlusion

Intravascular Spinal Perfusion

Electrical Nerve Stimulation

Retrograde Venous Perfusion

Thromboembolic Material Removal

Cooling Device

Occlusive Cerebrovascular Disease

Aortic Shunt

Collateral Blood Flow

49 patents: Sort by Forward Citations

1. 8221383 - Devices and methods for preventing distal embolization from the vertebrobasilar artery using flow reversal (2012-07-17),

2. 8137374 - Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature (2012-03-20),

3. 8034043 - Devices and methods for preventing distal embolization using flow reversal by partial occlusion of the brachiocephalic artery (2011-10-11),

4. 7993324 - Cerebral perfusion augmentation (2011-08-09),

5. 7927268 - Counterpulsation device with increased volume-displacement efficiency and methods of use (2011-04-19),

6. 7867195 - Partial aortic occlusion devices and methods for cerebral perfusion augmentation (2011-01-11),

7. 7635376 - Devices and methods for preventing distal embolization using flow reversal and perfusion augmentation within the cerebral vasculature (2009-12-22),

8. 7468027 - Partial aortic occlusion devices and methods for cerebral perfusion augmentation (2008-12-23),

9. 7458980 - Devices and methods for preventing distal embolization using flow reversal in arteries having collateral blood flow (2008-12-02),

10. 7452352 - Methods for preventing distal embolization from the vertebrobasilar artery using flow reversal (2008-11-18),

11. 7374561 - Devices and methods for preventing distal embolization during interventional procedures (2008-05-20),

12. 7340298 - Enhancement of cerebral blood flow by electrical nerve stimulation (2008-03-04),

13. 7166097 - Cerebral perfusion augmentation (2007-01-23),

14. 7150736 - Cerebral perfusion augmentation (2006-12-19),

15. 6942686 - Regulation of cerebral blood flow by temperature change-induced vasodilatation (2005-09-13),

CoAxia, Inc. is a medical device company focused on developing and commercializing innovative products for ischemic stroke treatment. Their mission is to improve patient outcomes by providing cutting-edge solutions to healthcare professionals. With a team of dedicated experts, CoAxia aims to revolutionize stroke care through advanced technologies and therapies. Visit their website to learn more about their groundbreaking solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

49 Patents

#5 in Maple Grove, MN

#198 in Minnesota

#7,133 in US

#14,256 in the World

Maple Grove, MN, United States of America

Coaxia, Inc.

Forward Citations = 4,946

7 inventors:

Denise R Barbut (49 out of 94 patents)

Jon St Germain (9 out of 42 patents)

Peter Trexler Keith (6 out of 165 patents)

4. Steven Wayne Berhow (5 out of 13 patents)

5. Russel H Patterson (4 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…